■ Qual o papel dos biomarcadores de lesão renal na nefropatia induzida por contraste
P P M Spineti
Arq Bras Cardiol 2021, vol 116 (6)
https://www.scielo.br/j/abc/a/NXVPS4VfkpmzZQj85WNpvmn/?lang=pt
■ Risco de insuficiência renal aguda pós-contraste em tomografia computadoriza: Estamos atentos à função renal
B C Juchem, F B de Sousa, C Karohl et al
Clinical & Biomedical Research 2019, vol 39 (1)
https://seer.ufrgs.br/hcpa/article/view/90598/pdf
■ Cognitive performance in dialysis patients – ¨when is the right time to test?
Hristos Karakizlis, Stefanie Thiele, Brandon Greene, Joachim Hoyer
BMC Nephrol. 2021; 22: 205
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171038/
■ Management of patient with a failed kidney transplant: what should we do?
Marco Fiorentino, Pasquale Gallo, Marica Giliberti, Vincenza Colucci et al
Clin Kidney J. 2021 Jan; 14(1): 98–106
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857798/
■ Routine immunohistochemistry study for polyomavirus BK nephropathy in transplanted kidney biopsies, is it recommended?
Fatemeh Nili, Maliheh Mohammadhoseini, Seyed Mohammadreza Khatami et al
BMC Nephrol. 2021; 22: 226
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212535/
■ Personalizing the kidney transplant decision: Who doesn´t benefit from a kidney transplant?
Deirdre Sawinski, David P. Foley
Clin J Am Soc Nephrol. 2020 Feb 7; 15(2): 279–281
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015096/
■ Assessment of patients referred to urgent start peritoneal dialysis: when does the nurse contraindicate?
Helen Caroline Ferreira, Fabiana Baggio Nerbass, Viviane Calice-Silva
J Bras Nefrol. 2021 Jan-Mar; 43(1): 47–51
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061952/
■ Does cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?
Carla Leal Moreira, Liliana Cunha, Sofia Correia et al
J Bras Nefrol. 2020 Jan-Mar; 42(1): 31–37
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213933/
■ Tyrosine kinase inhibitor-induced hypertension – marker of anti-tumour treatment efficacy or cardiovascular risk factor?
Anastasia G. Ptinopoulou, Ben Sprangers
Clin Kidney J. 2021 Jan; 14(1): 14–17
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857807/
■ Aspiration-sclerotherapy versus laparoscopic de-roofing in the treatment of renal cysts: which is better?
Xueling Zhang, Dehong Cao, Peizhen Han et al
BMC Nephrol. 2020; 21: 193
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245882/
■ Evidence in chronic kidney disease – mineral and bone disorder guidelines: is it time to treat or time to wait?
Jordi Bover, Pablo Ureña-Torres, Silvia Mateu et al
Clin Kidney J. 2020 Aug; 13(4): 513–521
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467585/
■ Renal function and delirium in older fracture patients: different information from different formulas?
E Mossello, G Rivasi, V Tortù et al
European Journal of Internal Medicine 2020, vol 71: p70-p75
https://www.ejinme.com/article/S0953-6205(19)30361-9/fulltext
■ Do virtual renal clinics improve acess to kidney care? A preliminary impact evaluation of a virtual clinic in East London
- A. Hull, V. Rajabzadeh, N. Thomas, S. Hoong et al
BMC Nephrol. 2020; 21: 1
https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-1682-6
■ Does chronic kidney disease predict stroke risk independent of blood pressure? A systematic review and meta-regression
Dearbhla M. Kelly, Peter M. Rothwell
Stroke. 2019 Nov; 50(11): 3085–3092.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824504/
■ Could IL-17A be a novel therapeutic target in diabetic nephropathy?
Carolina Lavoz, Sandra Rayego-Mateos, Macarena Orejudo et al
J Clin Med. 2020 Jan; 9(1): 272
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019373/
■ Is uric acid elevation a random finding or a causative agent of diabetic nephropathy?
M Z Kock, G Aktas, T T Duman et al
Rev Assoc Med Bras 2019, vol 65 (9)
https://www.scielo.br/j/ramb/a/kywbqX9NV45nDBtLsnVqpPR/abstract/?lang=en
■ Does chronic kidney disease result in high risk of atrial fibrillation?
Dapeng Zhang, Yibin Feng, Feona Chung-Yin Leung et al
Front Cardiovasc Med. 2019; 6: 82
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595216/
■ Do routine hospital data accurately record comorbidity in advanced kidney disease populations? A record linkage cohort study
Ailish Nimmo, Retha Steenkamp, Rommel Ravanan, Dominic Taylor
BMC Nephrol. 2021; 22: 95.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968235/
■ Significance of kidney biopsy dominant tubulointerstitial kidney disease – UMOD: is kidney biopsy truly nonspecific?
Tamehito Onoe, Satoshi Hara, Kazunori Yamada et al
BMC Nephrol. 2021; 22: 1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784305/
■ Sugar of fat? Renal tubular metabolism reviewed in health and disease
Leslie S. Gewin
Nutrients. 2021 May; 13(5): 1580
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151053/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Blog Internet Médica – www.internetmedica.com.br
Data: julho 2021